105 related articles for article (PubMed ID: 10660513)
1. Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacin.
Andrews JM; Wise R
J Antimicrob Chemother; 2000 Feb; 45(2):257-8. PubMed ID: 10660513
[No Abstract] [Full Text] [Related]
2. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
3. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
Reinert RR; Schlaeger JJ; Lütticken R
J Antimicrob Chemother; 1998 Dec; 42(6):803-6. PubMed ID: 10052905
[TBL] [Abstract][Full Text] [Related]
4. Activity of moxifloxacin against mycobacteria.
Gillespie SH; Billington O
J Antimicrob Chemother; 1999 Sep; 44(3):393-5. PubMed ID: 10511409
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae.
Hamamoto K; Shimizu T; Fujimoto N; Zhang Y; Arai S
Antimicrob Agents Chemother; 2001 Jun; 45(6):1908-10. PubMed ID: 11353651
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.
Boswell FJ; Andrews JM; Wise R
J Antimicrob Chemother; 2001 Sep; 48(3):446-7. PubMed ID: 11533016
[No Abstract] [Full Text] [Related]
7. Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.
Saravolatz L; Manzor O; Check C; Pawlak J; Belian B
J Antimicrob Chemother; 2001 Jun; 47(6):875-7. PubMed ID: 11389122
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species.
Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
J Infect Chemother; 2002 Mar; 8(1):115-7. PubMed ID: 11957133
[TBL] [Abstract][Full Text] [Related]
10. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
Rolain JM; Maurin M; Raoult D
Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of moxifloxacin against Staphylococcus aureus.
Berrington AW; Perry JD; Gould FK
Clin Microbiol Infect; 2001 Mar; 7(3):161-3. PubMed ID: 11318816
[No Abstract] [Full Text] [Related]
12. Susceptibilities of Propionibacterium acnes ophthalmic isolates to moxifloxacin.
Dali P; Giugliano ER; Vellozzi EM; Smith MA
Antimicrob Agents Chemother; 2001 Oct; 45(10):2969-70. PubMed ID: 11583007
[No Abstract] [Full Text] [Related]
13. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus.
Esposito S; Noviello S; Ianniello F; Novelli A
Chemotherapy; 2000; 46(1):23-7. PubMed ID: 10601794
[TBL] [Abstract][Full Text] [Related]
14. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
Iakovlev VP; Polushkina NR
Antibiot Khimioter; 2002; 47(5):19-29. PubMed ID: 12365324
[No Abstract] [Full Text] [Related]
15. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.
Hoogkamp-Korstanje JA; Roelofs-Willemse J
J Antimicrob Chemother; 2000 Jan; 45(1):31-9. PubMed ID: 10629010
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.
Sobottka I; Cachovan G; Stürenburg E; Ahlers MO; Laufs R; Platzer U; Mack D
Antimicrob Agents Chemother; 2002 Dec; 46(12):4019-21. PubMed ID: 12435716
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain.
Alós JI; Oteo J; Aracil B; Gómez-Garcés JL
J Antimicrob Chemother; 2001 Jul; 48(1):145-8. PubMed ID: 11418530
[No Abstract] [Full Text] [Related]
18. In vitro activity of moxifloxacin(BAY 12-8039) against respiratory tract pathogens from six Latin-American countries.
Cardeñosa G O; Soto-Hernández JL
Chemotherapy; 2000; 46(6):379-82. PubMed ID: 11053902
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution].
Watanabe M; Ishizuka K; Ikemoto T
Nihon Yakurigaku Zasshi; 2007 May; 129(5):375-85. PubMed ID: 17507775
[No Abstract] [Full Text] [Related]
20. Bactericidal activity of moxifloxacin against pneumococci.
Levy D; Berche P
Clin Microbiol Infect; 2001 Jan; 7(1):47-8. PubMed ID: 11284948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
